Topographic staging of tau positron emission tomography images

Alzheimer's Disease Neuroimaging Initiative

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods: Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results: All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Discussion: Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.

Original languageEnglish (US)
Pages (from-to)221-231
Number of pages11
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume10
DOIs
StatePublished - Jan 1 2018

Fingerprint

Positron-Emission Tomography
Amyloid
Neuroimaging
Alzheimer Disease
Pathology
Brain
Population

Keywords

  • Alzheimer
  • AV-1451
  • Braak
  • Classification
  • Flortaucipir
  • Image
  • PET
  • Stage
  • Staging
  • T807
  • Tau

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Topographic staging of tau positron emission tomography images. / Alzheimer's Disease Neuroimaging Initiative.

In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 10, 01.01.2018, p. 221-231.

Research output: Contribution to journalArticle

@article{33db6d63b40b4beeb660fb8868d2a492,
title = "Topographic staging of tau positron emission tomography images",
abstract = "Introduction: It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods: Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results: All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90{\%} to 94{\%} concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Discussion: Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.",
keywords = "Alzheimer, AV-1451, Braak, Classification, Flortaucipir, Image, PET, Stage, Staging, T807, Tau",
author = "{Alzheimer's Disease Neuroimaging Initiative} and Schwarz, {Adam J.} and Sergey Shcherbinin and Slieker, {Lawrence J.} and Risacher, {Shannon L.} and Arnaud Charil and Irizarry, {Michael C.} and Fleisher, {Adam S.} and Sudeepti Southekal and Joshi, {Abhinay D.} and Devous, {Michael D.} and Miller, {Bradley B.} and Andrew Saykin",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.dadm.2018.01.006",
language = "English (US)",
volume = "10",
pages = "221--231",
journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",
issn = "2352-8729",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Topographic staging of tau positron emission tomography images

AU - Alzheimer's Disease Neuroimaging Initiative

AU - Schwarz, Adam J.

AU - Shcherbinin, Sergey

AU - Slieker, Lawrence J.

AU - Risacher, Shannon L.

AU - Charil, Arnaud

AU - Irizarry, Michael C.

AU - Fleisher, Adam S.

AU - Southekal, Sudeepti

AU - Joshi, Abhinay D.

AU - Devous, Michael D.

AU - Miller, Bradley B.

AU - Saykin, Andrew

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods: Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results: All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Discussion: Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.

AB - Introduction: It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods: Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results: All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Discussion: Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.

KW - Alzheimer

KW - AV-1451

KW - Braak

KW - Classification

KW - Flortaucipir

KW - Image

KW - PET

KW - Stage

KW - Staging

KW - T807

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=85042732671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042732671&partnerID=8YFLogxK

U2 - 10.1016/j.dadm.2018.01.006

DO - 10.1016/j.dadm.2018.01.006

M3 - Article

AN - SCOPUS:85042732671

VL - 10

SP - 221

EP - 231

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

SN - 2352-8729

ER -